AMPK is a central energy sensor linking extracellular milieu fluctuations with the autophagic machinery. In the current study we uncover that Poly(ADP-ribosyl)ation (PARylation), a post-translational modification (PTM) of proteins, accounts for the spatial and temporal regulation of autophagy by modulating AMPK subcellular localisation and activation. More particularly, we show that the minority AMPK pool needs to be exported to the cytosol in a PARylation-dependent manner for optimal induction of autophagy, including ULK1 phosphorylation and mTORC1 inactivation. PARP-1 forms a molecular complex with AMPK in the nucleus in nonstarved cells. In response to nutrient deprivation, PARP-1 catalysed PARylation, induced the dissociation of the PARP-1/AMPK complex and the export of free PARylated nuclear AMPK to the cytoplasm to activate autophagy. PARP inhibition, its silencing or the expression of PARylation-deficient AMPK mutants prevented not only the AMPK nuclear-cytosolic export but also affected the activation of the cytosolic AMPK pool and autophagosome formation. These results demonstrate that PARylation of AMPK is a key early signal to efficiently convey extracellular nutrient perturbations with downstream events needed for the cell to optimize autophagic commitment before autophagosome formation. Macroautophagy (hereafter called autophagy) is an evolutionarily conserved pathway involving the formation of a doublemembrane vesicle, the autophagosome, which engulfs cytoplasmic components and delivers them to the lysosome for degradation.
3-5
The intracellular mechanisms that spatially and temporally fine-tune the initiation of autophagy still remain poorly understood. Poly(ADP-ribose) polymerase-1 (PARP-1) catalyzes the conversion of NAD + to polymers of Poly(ADP-ribose) (PAR) in a process called PARylation which plays different pleiotropic cellular roles ranging from DNA damage sensing to transcription, chromatin relaxation or cell death. 6 We have recently shown that during starvation-induced autophagy PARP-1 activation is involved in amplifying autophagy by feeding-back ROS production/DNA damage/NAD + consumption axis. 7 In the present study we uncover a new and unexpected role for PARylation in the early signalling of autophagy: PARP-1 activation leads to AMPK PARylation, dissociation of PARP-1-AMPK complex and the nuclear-tocytosolic export of AMPK, an event needed to induce mTORC1 inactivation/ULK1 phosphorylation in the cytosol. Together, these findings identify a new regulatory mechanism in autophagy and expand the known functions of AMPK and PARP-1 to include spatial regulation of the early signals of autophagy in mammalian cells.
Results

PARylation regulates starvation-induced autophagy.
To analyze the importance of PARylation in starvation-induced autophagy we used the breast cancer cell line MCF7 cells 1 stably transfected with GFPLC3. PARP-1 is the best studied member of the PARP protein family accounting for around 90% of cellular PARylation activity following different stimuli. 8, 9 Recent studies have demonstrated its involvement in the regulation of DNA damage-or starvation-induced autophagy. 10, 11 To correlate PAR production with starvation, we used the PARP inhibitors PJ34, DPQ and olaparib, iPARP-1 and iPARG (Poly Figure S1b) . In contrast in PARG-depleted cells, the accumulation of PAR accelerated autophagy after nutrient deprivation ( Figure 1a ). It has been reported that PAR accumulation may induce cell death (called PARthanatos), 12 however this was not the case as PAR accumulation after nutrient deprivation did not compromise cell viability (Supplementary Figure S1d) . Thus, the increased level of autophagy was not ascribed to a cellular attempt to detoxify the excess of PAR in autophagosomes, but there may be a mechanism of fine-tuning in the induction of PARylation-mediated autophagy. Fluorescent microscopic images showed an Figure 1 Poly(ADP-ribose) regulates autophagy during nutrient deprivation. (a) Effect of PARG silencing, PARP silencing and PARP inhibition on starvation-induced autophagy. MCF7 GFPLC3 cells were transfected with PARP-1 siRNA (60 nM) or PARG siRNA (30 nM) . 48 h later cells were starved with HANK Buffer. Other cells were pretreated with 10 μM PJ34 for 1.5 h and maintained during the nutrient deprivation. * Po0.05, **Po0.01, ***Po0.001 versus the indicated group in MCF7 GFPLC3 cells by t-test. Western blot and qPCR for PARP-1 and PARG knock-down are shown. (b) Autophagy as active process dependent of PARylation levels. MCF7 GFPLC3 cells were transfected with PARG siRNA (30 nM) . 48 h later, 3-MA (5 mM) and Bafilomycin A1 (0.2 μM) were used as autophagy inhibitors during the starvation treatment. 10 μM PJ34 for 1.5 h and maintained during the nutrient deprivation was used as PARylation inhibition control. * Po0.05, **Po0.01, ***Po0.001 versus the indicated group by t-test in MCF7 GFPLC3 cells. Lower panel shows endogenous LC3-II protein conversion during starvation, PARG siRNA or PJ34, alone or in co-treatment with 3-MA and Bafilomycin A1. α-tubulin was used as loading control. (c) Effect of PAR accumulation on starvation-induced autophagy. ShVector and shPARG A549 cells were starved with HANK buffer. The right panel shows the effect of PARPs inhibitor on the endogenous starvation-induced LC3-II conversion. α-tubulin was used as loading control. *Po0.05, **Po0.01 versus the indicated group in shVector and shPARG A549 cells by t-test. (d) Effect of ULK1 silencing on starvation-induced autophagy. ShVector and shPARG A549 cells were transfected with ULK1 siRNA (50 nM). 48 h later cells were starved with HANK buffer. The right panel shows the effect of ULK1 silencing on ULK1 protein levels and the endogenous starvation-induced LC3-II conversion in shPARG A549 cells. α-tubulin was used as loading control *Po0.05, **Po0.01, ***Po0.001 versus the indicated group in shVector and shPARG A549 cells by t-test. In all cases, at least 250 cells were counted in a Zeiss fluorescent microscope and data were represented as mean ± S.E.M. of 3 independent experiments. In A, B and D figures scrambled or non-specific siRNA was used as negative control increased accumulation of autophagosomes in siPARG cells while inhibition of PARylation or PARP-1 knock-down abrogated starvation-induced autophagy (Supplementary Figure S1e) . To analyze if PARylation-associated autophagy was an active process, we studied the membrane traffic associated to nutrient deprivation in presence of PARP inhibitors or PARG knock-down in combination with the autophagy inhibitors 3-MA, Chloroquine and Bafilomycin A1. Doses of autophagy inhibitors were established in MCF7 GFPLC3 during nutrient deprivation (Supplementary Figure S1f) . By using the co-treatment of PARP inhibitors or siPARG in combination with 3-MA and Bafilomycin A1, we demonstrated that starvation-induced autophagy is an active process dependent of PAR levels and PARP activity (Figure 1b) , as Bafilomycin A1 recovered the rate of autophagic cells and increased LC3-II translocation in starved cells treated with PJ34 or siPARG. To confirm the role of PAR in autophagosome formation, we used A549 cells stably-depleted for PARG 13 which showed increased starvation-associated PARylation. Besides, PAR accumulation during nutrient deprivation did not affect to cell survival (data not shown) and induced a rapid translocation of LC3-II protein, compared with starved A549 shVector cells (Figure 1c and data not shown).
A549 shPARG cells accumulated more autophagosomes compared with A549 shVector cells (Figures 1c and d and Supplementary Figure S2a) . To further evaluate the impact of PAR, cells were treated with PJ34, which reduced the levels of starvation-induced autophagy in parental and shPARG cells (Figure 1c) . Accordingly, LC3-II translocation in A549 shPARG cells disappeared after PARP inhibition ( Figure 1c) . Next, we evaluated the role of PAR synthesis in starvation-induced autophagy after silencing ULK1 which blocked autophagosome formation and LC3II translocation during starvation in both A549 cell lines (Figure 1d ). These results suggest a dynamic interaction between PAR and the initiation of autophagy. In addition, silencing of other ATG-related protein as ATG7, confirmed the results obtained in starved A549 shPARG cells (Supplementary Figure S2b) . All these data indicated that starvation-induced PARylation is directly and actively involved in autophagy formation.
Inhibition of PARylation down-regulates AMPKα activation and autophagy induction. The cellular metabolic status is sensed by two essential proteins, AMPK as an energetic sensor and mTORC1 complex as a nutritional sensor. [14] [15] [16] Under energy rich levels, active mTORC1 acts as a negative regulator of autophagy, allowing proliferation and cell growth. On the contrary, AMPK is activated under energy depletion, and it is a positive regulator of autophagy, through in part inhibiting mTORC1. 17 In view of the connection between PAR synthesis and the energy status of the cell we aimed to evaluate AMPK (hence forth AMPKα) during nutrient deprivation; we firstly observed a time-dependent decrease on ATP levels in MCF7 GFPLC3 cells following starvation (Supplementary Figure S3a Figure  S1a) , we hypothesized that the levels of PAR could regulate AMPKα activation. In line with this result, both PJ34 treatment or iPARP1 prevented starvation-induced ATP depletion (Figure 2a) , implying that over-activation of PARP-1 during starvation was the main cause of energy drop in the starved cells. In addition, PJ34 treatment and iPARP-1 recovered ATP levels while AMPKα and autophagy were fully inactive ( Figure 1a and Figure 2b ). PARG silencing had no effect on ATP levels during starvation (Figures 2c and d) . In starved MCF7 GFPLC3 cells, inhibition of autophagy in the initial steps with 3-MA, totally abrogated the activation of AMPKα (Supplementary Figure S3b) ; however there was no effect on AMPK activation after combination with Bafilomycin A1 suggesting that PARylation was affecting early autophagy events where ATP depletion and AMPK activation is taking place. To confirm the functional link between PARP-1 and AMPK, we used parp- (Figure 2g ). All these data suggest that the presence and proper function of PARP-1 was needed for the adequate activation of AMPKα and for starvation-induced autophagy.
Activation of nuclear and cytosolic AMPK requires PARylation-dependent dissociation of the PARP-1/AMPK complex from PARP-1. We then aimed to investigate whether PARP-1 interacts with AMPKα and if PARP-1 modifies its kinase activity by PARylation. To this end we performed co-IP assays at different times after starvation. Co-IP experiments revealed an interaction between PARP-1 and AMPKα in fed cells (Figure 3a) . After starvation we observed a gradual and time-dependent dissociation of the PARP-1-AMPK complex (Figure 3a ) with complete dissociation reached 30 min upon nutrient deprivation. This dissociation, in turn, allowed AMPKα activation (Figure 3a INPUT) , concomitant with the inactivation of mTORC1 and autophagy induction shown above (Figure 2 ). To substantiate this physical interaction between PARP-1 and AMPKα we measured the percentage of co-localization in starved MCF7 GFPLC3 cells observing that diminished to 6% after 30 min of starvation (Figure 3b) .
To get more insights about the interaction between PARP-1 and AMPKα, we mapped the domains of PARP-1 involved in this interaction. PARP-1 was dissected in three domains cloned with GST fusion protein 18 as explained in Supplementary Figure S4a . These constructs were expressed in Cos1 cells and the co-IP of endogenous AMPKα was analyzed by GST-pulldown. Starvation-induced autophagy was confirmed to be efficient in Cos1 cells (Supplementary Figure S4b) . The results indicated that AMPKα interacts efficiently with the catalytic domain of PARP-1 and to a lesser extent with the ABC and D domains (Figures 3c and d) . Next, we starved COS1 cells co-transfected with both pcDNA3-FLAG-AMPKα and GST-fused PARP-1 to confirm that the AMPK/PARP-1 complex dissociated shortly after starvation ( Figure 3d ). Indeed, the interaction between AMPKα and PARP-1 moved-out confirming the endogenous co-IP in MCF7 GFPLC3 cells (Figure 3a ). Finally we analyzed the role of PARP activity in PARP-1/AMPK complex stability and found that PJ34 prevented dissociation of the PARP-1/ AMPK complex after starvation ( Figure 3e ). Together, these (Figure 3g ). To evaluate the possibility of a mutual interaction between AMPK and PARP-1 leading to PARP-1 phosphorylation, as has been described before, 19 we treated the cells with the AMPK inhibitor Compound C which indeed prevented AMPK activation and decreased PARylation associated to AMPK (Figure 3h ) suggesting that full AMPK activity was needed for PARP activation. Taken together, these data suggest that PARP-1 activation during starvation signals PARP-1/AMPK complex dissociation, to activate AMPKα in a PARylation-dependent manner.
To strengthen the previous findings we generated different mutants of AMPK deficient for Poly(ADP-ribosyl)ation putative sites (Figure 4a ). Expression of mutated proteins, followed by coIP with the anti-PAR antibody confirmed that AMPK mutants (AMPK PARdef ) were indeed PARylation deficient in the following order: 1424443 (Figure 4b and Supplementary Fig. S5a ). The most important residues were K291 and E292 whose change to A almost completely abolished AMPK PARylation (Figure 4b ). We also verified that AMPK PARdef1 interacted with PARP-1 under basal (non starved) situation. By GST-pulldown assay in Cos1 cells we confirmed that the AMPK PARdef1 formed a stable complex with the full protein and the catalytic domain of PARP-1 under optimal nutrient conditions (Figures 4c and d) .
After PARP inhibition and in AMPK PARdef1 this interaction remained in starved cells (Figure 4c ). The interaction between AMPK PARdef1 and PARP-1 took place in the domains EF of PARP-1 and after PARP inhibition the complex increased under nutrient-rich conditions (Figure 4d ).
All these data suggest that PARP-1 and AMPK form a stable complex under rich energy situation. The correct activation of PARP-1 and the modification by PAR of AMPKα are essential events in the disruption of the complex to induce total activation of AMPK under nutrients poor status.
PARylation and nuclear export of AMPKα. Autophagy is a predominantly cytosolic pathway; thus we hypothesized that AMPKα modified by PAR (PAR-AMPK) would be exported from the nucleus to the cytosol to regulate the initial steps of ). Finally the mutants were tagged with FLAG oligopeptide and subcloned in pCDNA3 plasmid, obtaining two specific vector pCDNA3-FLAG-AMPkα wt and pCDNA3-FLAG-AMPkα mut. Each mutant represents the following changes: PARdef1: The residues K305,E306,K310,E315,E316,E317 were mutated in A: PARdef2: The residues K305,E306 were mutated in A: PARdef3: The residues E315,E316,E317 were mutated in A: PARdef4: The residues K310 was mutated in A. To confirm the impact of the nuclear-cytosolic export of PAR-AMPKα in autophagy, we used Leptomycin B which led to nuclear accumulation of AMPKα. Moreover, the activation of AMPKα after 30 min of starvation declined after Leptomycin B treatment (Figure 5b ). The levels of autophagic cells (and autophagosomes per cell) at 30 min of starvation decreased with Leptomycin B compared to untreated starved (Figure 5c ). Finally we demonstrated that AMPK PARylation was necessary to induce its nuclear export during starvation using the AMPK PARdef mutants which were unable to undergo nuclear export, similar to the results obtained after PARP inhibition (Figure 5d ). The presence of AMPK PARdef abrogated the activation of AMPK in cytosol (Figure 5d ) and totally inhibited the induction of autophagy (Figure 5e ).
Inhibition of PARylation prevents mTORC1 downregulation and ULK1 activation during autophagy. Once activated by falling energy status, AMPK switches-on ATPproducing catabolic pathways such as autophagy. Under nutrient-rich conditions mTORC1 interacts with ULK1 complex inactivating the autophagosome formation. However, during starvation the energy depletion induces AMPK activation and mTORC1 inactivation.
We asked for the consequences of PAR-AMPKα nuclear export on ULK1 activation. First we analyzed the interaction AMPKα/ULK1 during starvation and the effect of PARP inhibitors. Co-IP and co-localization assays in MCF7 cells, showed that after 30 min of starvation AMPKα interacted with ULK1, confirming the sequence of events from activation/ PARylation and nuclear export of AMPKα after starvation (Figures 6a and b) . Starvation during 30 min was sufficient to provoke activation of ULK1, total inhibition of mTORC1 and endogenous LC3-II translocation (Figure 6b ). Interestingly PARP inhibition disabled the interaction AMPKα/ULK1 during starvation, as the percentage of endogenous co-localization of both proteins decreased in starved cells treated with PARPi (Figure 6c ). We have demonstrated that PAR-AMPK shuttled from nucleus to cytosol during starvation and interacted with ULK1 to promote its proper activation favouring the initial steps in the autophagosomes formation. Immunoprecipitation of AMPK in presence of the PARP inhibitor Ku0058948 demonstrated that PARylated-AMPK formed a stable complex with ULK1 protein (Figure 6d) . But, was this modification needed to maintain AMPK/ULK1 complex? To address this question we measured the activation of ULK1 following starvation in the presence of PARP inhibitors and we found that PARPi prevented ULK1 phosphorylation (Figure 6e) . Consistently, PARP1 knockdown in starved MCF7 GFPLC3 cells impeded ULK1 (as well as Raptor) phosphorylation, GFPLC3 cells were transfected with PARP-1 siRNA (60 nM). scrambled or non-specific siRNA was used as negative control, using the same protocol as for siRNA transfection. 48 h later were starved with HANK Buffer for 15, 30 and 60 min. In A, C, E and F figures total ULK1, p70s6 and Raptor kinase were used to normalize for the non-phosphorylated protein. α-tubulin and β-actin were used as loading control. Similar results were obtained in three independent experiments leading to the recovery of mTORC1 activity and the inhibition of autophagy (Figure 6f ).
All these data suggest that PARylation is a crucial PTM on AMPK to induce an optimal activation and loading of ULK1 complex eventually leading to induce autophagosomes formation.
Discussion
Autophagy is regulated by a highly interconnected arrangement of proteins are involved in the control of key cellular processes. Autophagic responses in conditions of nutrient deprivation serve metabolic purposes and various intracellular entities can be degraded to provide the cell with metabolic substrates for survival. In response to nutrient deprivation AMPK is activated upon the accumulation of AMP at the expense of ATP. Multiple signal transduction pathways that ultimately accelerate or inhibit the autophagic flux do so by impacting on the activation state of AMPK and/or mTORC1. 16, 20 AMPK functions as a fuel gauge and maintains energy homeostasis during cellular stress 21 and is activated by changes in the cellular AMP:ATP and ADP:ATP ratios. AMPK functions to restore energy homeostasis by switching-off biosynthetic pathways consuming ATP while switching-on catabolic pathways that produce ATP. Upstream kinases phosphorylate the critical Thr172 activating site and include liver kinase B1 (LKB1), calcium-calmodulin-dependent kinase kinase 2 (CaMKK2) and transforming growth factor-β-activated protein kinase-1 (TAK1). 22 PTM regulation of autophagy has been extensively reported and mechanisms including phosphorylation, glycosylation, ubiquitination, acetylation and lipidation have been shown to be critical in the ability of ATGs and other autophagy-related proteins to interact with regulators of this route. 23 In the present study we demonstrate that the modification of AMPK by PARylation and the mutual interaction between PARP-1 and AMPK function as a multifaceted molecular switch to optimize the initiation of autophagy summarized in Figure 7 : (1) non-PARylated nuclear AMPK is inactive when in complex with PARP-1 in non-starved cells; (2) following starvation PARP-1 is activated and AMPK is transiently PARylated and detached from PARP-1; (3) complex dissociation and AMPK PARylation trigger kinase activation which is needed to undergo AMPK nuclear export and activation of the cytosolic AMPK pool.
Interaction between PARP-1 and AMPK has been previously shown to be needed for DNA-damage dependent PARP-1 activation and PARP-1 has been reported to be a substrate of AMPK. 19, 24 The molecular insights for this mutual interaction still remain to be fully elucidated. Our results suggest that AMPK activation is hindered by its interaction with PARP-1 that most likely will be in turn phosphorylated by AMPK following starvation. Indeed, both global and AMPKassociated PARylation are decreased in the presence of the AMPK inhibitor compound C (Figure 4e ). DNA binding domain of PARP-1 has been reported to be phosphorylated by AMPK at Ser-177 leading to PARP-1 dissociation from Bcl-6 promoter. 24 Given the highly elaborated nature of the autophagic pathway, the mutual regulation of AMPK and PARP-1 is likely to be complex and future studies are required to have a comprehensive understanding of this crosstalk in response to the wide range of autophagy-inducing signals.
One of the most remarkable finding in this study is the need of AMPK nuclear export to perform its cytosolic function during the induction of starvation-induced autophagy but how PARylated AMPK coming out of the nucleus 'hits' cytosolic AMPK remains to be clarified. The nucleus has been implicated in the initiation of autophagy as a primary site of conditions that are potentially toxic for mammalian cells, as they cause DNA damage or perturb/prevent proper DNA replication. 25 Nuclear sensors, including PARP-1, detect perturbations in nuclear and genetic homeostasis, to activate mechanisms for the repair of cellular damage and, if these fail, trigger different types of cell death for the benefit of organismal homeostasis. Increasing evidences indicate that repair of DNA lesions activate a non-selective autophagic response. 26 The fine-tuning of key biological processes, other than DNA repair, through PARylation is still largely unknown. Our study provides new implications of PARylation as a dynamic process in autophagy beyond PARP-1 activation and its association with DNA repair and energy balance, as has been reported previously. 7, 27 Our results place the nucleus and the interaction between PARP-1 and AMPK as an initial sensor of the metabolic alterations derived from perturbations in the nutritional extracellular status not necessarily related with the alterations in genomic integrity.
PARylation as a PTM process may also be involved in the regulation of more downstream autophagy events. Our results show that activation of ULK1/inactivation of mTOR might also be modulated by PARylation, although the precise substrates have not been defined. PARylation has also been recently implicated as regulatory signal for proteasomal-mediated protein degradation. 28 In summary, our study supports a model where PARP activation and PAR levels during starvationinduced autophagy leads to global modulation of autophagic fluctuations and more specifically induce de-repression of AMPK activity (Figure 7 ). Until now, nuclear events have not been considered to be of critical importance for autophagy. Our data, however, uncover an essential connection between the induction of autophagy and AMPK PARylation which determines its export out of the nucleus to unleash the early cytosolic events of autophagy, including inhibition of mTORC1 and derepression of ULK1-kinase (Figure 7b) . Previous results have shown that in cytoplasts/enucleated cells the autophagic process is still feasible. 29 Our findings do not contradict the previous conclusions about functionality of the autophagic process in enucleated cells, but add a new early regulatory axis influencing the outcome of autophagy. The discovery of tightly regulated PAR-modified proteins associated with the autophagic process offers a striking conceptual context to understand the short-term response to stimuli eliciting autophagy. Participation of nuclear AMPK in autophagy is needed to convey a rapid response of the alteration in the metabolic status, indicated by the level of PARylation as an alert indicator of changes in the energy balance. Cells deficient in PARP-1 are still able to undergo starvation-induced autophagy but the outcome of this delay may imply important consequences for the time-frame of drug treatment and the sensitization of tumor cell in their microenvironment to different combinatorial regimes including PARP inhibitors.
Materials and Methods
Cell cultures and treatments. MCF7 GFP-LC3 cells were cultured in RPMI 1640 GlutaMAX (GIBCO Invitrogen) with 6% inactive fetal bovine serum (FBSi, Gibco Invitrogen) and Pen/Strep (P4333, Sigma-Aldrich, St Louis, MO, USA). Immortalized mouse embryonic fibroblast (MEFs 3T3), derived from both wild-type and PARP-1 KO mice, cell lines were cultured in Dulbeco's Modified Eagle's Medium (DMEM) supplemented with 10% FBSi. ShVector and shPARG A549 cell lines were cultured in DMEM supplemented with 10% FBSi, L-Glutamine 2 mM, Pen/Strep and 5 μg/ml Puromycin and selection antibiotic. ShVector and shPARGHeLa cells were cultured in DMEM supplemented with 10% FBSi, Gentamicin 50 ng/ml and Hygromycin B 1:400 as antibiotic selection. All cell lines were maintained at 37°C in a humidified 5% CO 2 atmosphere. Cells were starved with Balanced HANK Buffer without Aminoacids (140 mMNaCl, 5 mM KCl, 1. Figure 7 PARylation regulates autophagy through AMPK activation:. PARP-1 forms a complex with AMPK in nucleus (1) . During the starvation-induced autophagy ROS production induces DNA damage and overactivation of PARP-1. Auto PARylated PARP-1 is able to modify by PARylation AMPK in AMPKα1 subunit (2) . The complex is disrupted and PAR-AMPK is exported to cytosol (3). Presence of PAR-AMPK and continuous absence of Aminoacids and ATP depletion, favours total activation of AMPK population, inhibition of mTORC1, interaction PAR-phospho-AMPK/ULK1 and autophagosomes formation (4) . (a). Starvation-induced ROS production was abrogated during the treatment with PARP inhibitors. Following AMPKα1/PARP-1 interaction (1), AMPKα1 subunit is not PARylated and nuclear export of AMPK is inhibited (2 and 3). In spite of nutrient and energy depletion, AMPK is inhibited, mTORC1 is partially activated and interacts with ULK1 favouring it's inhibition (4) . Finally the autophagosomes production will be delayed (b)
Immunofluorescence. Immunostaining for poly (ADP-ribose) (PAR) was performed on cells grown on glass cover-slips (density of 3.5 × 10 4 cells per well and in 6-well plates) and fixed with 3% paraformaldehyde, 2% sucrose, PBS1x solution for 10 min RT. Fixed cells were permeabilized with 0.5% Triton-X100, PBS1x solution for 5 min RT and blocked with 2% BSA PBS1x for 1 h at 37 ºC. Poly (ADP-ribose) was detected using monoclonal antibody (PAR) (20591E10, TREVIGEN, My) 1:600 and cy3-conjugated goat anti-mouse immunoglobulin (C2181-1 ML, Sigma-Aldrich) 1: 800 in 2% BSA PBS1x solution. Nuclear counterstaining with DAPI (1:5000 in PBS1x) was performed after removal of excess secondary antibody. Cells were mounted on microscope slides with Vectashield mounting medium for fluorescence (H-1000, Vector, CA). Immunostaining was visualized with a Zeiss Fluorescence Microscope.
ATP determination. Cell lines were plated in 6-well plates with a density of 5 × 10 5 cells per plate. Intracellular ATP was measured using a luciferin/luciferasebased assay (Adenosine 5'-triphosphate (ATP) Bioluminescent Assay Kit, SigmaAldrich) following manufacturer's guidelines. A standard curve was generated rather than known concentrations of ATP and used to calculate sample ATP concentrations. Protein concentration was determined using Bradford protein assay reagents (Bio-Rad). The content of ATP was normalized for protein content and expressed as percentage of control. RNA interference. These assays were performed on cells grown on glass cover-slips (6 × 10 4 cells per well) in 6-well plates for fluorescence microscopy and 9 × 10 4 cells in 6-well plates for western blot assays in RPMI 1640 GlutaMAX (GIBCO Invitrogen) with 6% FBSi without antibiotic. Cells were transfected with the indicated siRNAs at 50 nM (iBclin1 and iATG7), 60 nM (iPARP-1 and iULK1), 30 nM (iPARG and iLAMP1) using Lipofectamine TM reagent (Invitrogen) or JetPrime reagent (Polyplus Transfection, Illkirch, France), according to the manufacturer's guide. SiRNA corresponding to the cDNA sequences were: ATG7, ULK1 from Sigma, Human PARP-1 from Ambion Applied Biosystems and Beclin1, PARG and LAMP1 from Santa Cruz Biotechnology. After 48 h after of transfection, cells were treated as described and observed under a Zeiss Fluorescence Microscope or the proteins were extracted.
Cell viability assay. MCF7 GFPLC3 cells were seeded in 24-well plates with a density of 1.2 × 10 4 cells per well, with different treatments with HANK buffer. The levels of cell viability were determined using MTT Cell Proliferation Kit I (1-65-007, Roche, Mh, Germany). MTT assay (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyl Tetrazolium Bromide, ) was performed following manufacturer's instructions.
Co-Immunoprecipitation. MCF7 GFPLC3 cells were plated in p100 plates with a density of 1 × 10 6 cells per plate. After starvation, cells were washed 2 times with PBS1x Pefabloc 0.5 mM, resuspended in 200 μl of Lysis Buffer EBC (50 mMTris-HCl pH8, 120 mMNaCl, 0.5% NP-40, 1 mM PMSF, Protease Inhibitor Complete Mini Roche), on ice 30 min, vortex 3 times. Centrifuge 13.000 rpm 20 min 4°C and obtained the INPUT, the rest of supernatant was incubated with 35 μl of Protein Sepharose A (PAS) 30 min 4°C rocking. 13.000 rpm 5 min 4°C to obtain the Pre-Immune (PI) supernatant using anti-Cyt C (sc-7159, Santa Cruz Biotechnology, Santa Cruz, CA) and pellet in 50 μl EBC Buffer with PAS, rocking 1-2 h 4 ºC. Co-IP of AMPk and PARP-1 or AMPk and ULK1 endogenous proteins performed using AMPk, PARP-1 and ULK1 (1:100) antibodies previously described. Co-IP was incubated at 4°C o/n rocking and centrifuged 13.000 rpm 5 min 4 ºC. Pellets were washed 5 times with 500 μl NET-N buffer per sample (20 mMTris-HCl pH8, 100 MNaCl, 0.5% NP-40, 1 mM EDTA, 1 mM PMSF, Protease Inhibitor Complete Mini Roche) 13.000 rpm 4°C 5 min. Finally the pellet was resuspended in Loading Buffer 2x and maintained at -20 ºC.
AMPk mutation in PARylation sites. Amino acids which can be potentially PARylated in AMPK were searched in silico and selected according to previously described PARylation consensus sequences and in particular the PAR acceptor aminoacids found for the transcription factor CTCF that were conserved in AMPKα. 30 Mutations of such individual amino acids (K to A or E to A as specified in Figure 4a ) generated 4 mutants (AMPK PARdef1, 2, 3, 4 ) and Wild Type constructs were tagged with FLAG oligopeptide and sub-cloned in pCDNA3 expression vector (pCDNA3-AMPKα1-FLAG). Total structure from AMPk alpha 1 protein was screened comparing with different putative PARylated motives in different proteins. Putative PARylation site in AMPK alpha1 subunit (DEALKEVCEKFECSEEEVLS) was identified comparing with CTCF transcription factor, previously described as Poly ADP-Ribose acceptor TEEG-KDVDVSVYDFEEEQQ. 31 AMPkα deficient in PARylation1 mutant (AMPK PARdef1 ) was generated using de novo synthesis and sub cloning in a XhoI site in pCDNA3 expression vector (pCDNA3-AMPKalpha1-FLAG).
AMPkα deficient in PARylation mutants 2, 3 and 4 were carried out using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs, Ipswich, MA). A pcDNA3-flag plasmid carrying the wild type AMPK cds was used as template. Orientation, integrity and fidelity of all the cloned fragments were checked by Sanger sequencing.Plasmids were transfected with JetPEI co-transfection according to the manufacturer's guide.
PARylation assay. ShPARG HeLa cells were plated in p100 plates with a density of 1 × 10 6 cells per plate and transfected with JetPEI reagent (Polyplus Transfection, Illkirch, France) with the plasmid pcDNA3-FLAG-AMPkα containing the wildtype and mutant forms of AMPk alpha 1 subunit, according to the manufacturer's guide. Twenty-four hours later, cells were starved at different times with HANK Buffer. After starvation, cells were washed 2 times with PBS1x Pefabloc 0.5 mM, resuspended in 500 μl of Lysis Buffer EBC ( 50 mMTris-HCl pH8, 120 mMNaCl, 0.5% NP-40, 1 mM PMSF, 1 mM Na 3 VO 4 , 10 mMNaF, Protease Inhibitor Complete Mini Roche), on ice 20 min. Centrifuge 13.000 rpm 20 min 4°C and obtained the INPUT, the rest of supernatant was incubated with 35 μl of Protein Sepharose A (PAS) 1 hour 4°C rocking. IP of endogenous PAR polymer performed using PAR (1:50) polyclonal antibody (4336-APC-050, TREVIGEN, My). IP was incubated at 4°C o/n rocking and centrifuged 13.000 rpm 5 min 4 ºC. Pellets were washed 4 times with 500 μl of EBC 250-120 mMNaCl. Finally the pellet was resuspended in Loading Buffer 2x and maintained at -20 ºC.
GST-Pulldown. COS1 cells were seeded (1 × 10 6 ) on p100 plates and transfected with JetPEI TM co-transfection (Polyplus Transfection, Illkirch, France) with the plasmids expressing FLAG-AMPkαwildtype and mutant, GST-PARP-1 full fusion proteins and ABC, D and EF PARP-1 domains and GST fusion protein as transfection control; according to the manufacturer's guide. Forty-eight hours later, cells were washed with PBS1x Pefabloc and lysed in B buffer (20 nMTris-HCl (pH 7.5), 400 mMNaCl, 20% glycerol, 5 mM DTT, 0.5 mMPefabloc,NP40 0.5%, protease inhibitors (Complete Mini; Roche, Mannheim, Germany)). Lysates were cleared by centrifugation (10.000 rpm 15 min 4 ºC) and incubated for 2 h with glutathione-Sepharose 4B (Amersham). Beads
